SuperworthUroGen Pharma shares outstanding URGN
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Dec 31, 2021
- 22.4M
- On a year earlier
- +1.3%
- more shares
UroGen Pharma had 22.4M diluted shares outstanding on average in Q4 FY21, the quarter to Dec 31, 2021.
That is 1.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 22.4M | +1% |
| FY2020 | 22.1M | +6% |
| FY2019 | 21M | +32% |
| FY2018 | 15.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY21 | 22.4M | +1% | |
| Q3 FY21 | 22.4M | +1% | |
| Q2 FY21 | 22.3M | +3% | |
| Q1 FY21 | 22.2M | +5% | |
| Q4 FY20 | 22.1M | +6% | |
| Q3 FY20 | 22.1M | +5% | |
| Q2 FY20 | 21.8M | +4% | |
| Q1 FY20 | 21.2M | +9% | |
| Q4 FY19 | 21M | +32% | |
| Q3 FY19 | 20.9M | +30% | |
| Q2 FY19 | 20.8M | +32% | |
| Q1 FY19 | 19.3M | +27% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on UroGen Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.